loader

World Tenders & Procurement Opportunities

Search
Advanced Search

Awarded - 120781- Germany – Pharmaceutical products – Drug discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredients Eptacog beta and Willebrand factor

World Biggest Tenders Source

This tender with title Awarded - 120781- Germany – Pharmaceutical products – Drug discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredients Eptacog beta and Willebrand factor has been published on Bidding Source portal dated 26 Feb 2026 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

Awarded - 120781- Germany – Pharmaceutical products – Drug discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredients Eptacog beta and Willebrand factor
Contract Award
120781
Germany
26 Feb 2026
English
Pharmaceutical products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

120686- Germany – Pharmaceutical products – Conclusion of non-exclusive agreements for medicinal products containing the active ingredient relugolix (ATC code: L02BX04) by way of an open-house model Germany Awarded - 121069- Germany – Pharmaceutical products – Drug discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient Concizumab Germany 122544- Germany – Pharmaceutical products – Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V, by way of an open-house model for the active ingredient pegfilgrastim (WHO ATC code: L03AA13) Germany 122067- Germany – Pharmaceutical products – Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V, by way of an open-house model for the active ingredient sultiam (WHO ATC code: N03AX03) Germany 116029- Germany – Pharmaceutical products – Drug contracts with accession option Germany 116153- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient Interferon beta-1b, ATC L03AB08 for the period 01.04.2026 - 31.03.2028 Germany 114799- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient galcanezumab, ATC N02CD02, for the period 01.04.2026 - 31.03.2028 Germany 115175- Germany – Pharmaceutical products – Open-House-Rabattverträge 2026-03 Germany 117820- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 or 130c Paragraph 1 of the German Social Code, Book V (SGB V) for the period from April 1, 2026 to, as a rule, March 31, 2028 Germany 115409- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient lanreotide, ATC H01CB03, for the period 01.04.2026 - 31.03.2027 (plus extension option of 1 x 12 months) Germany
Pharmaceutical products Tenders
Germany Tenders
Europe Tenders
Tenders
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans